User:Yayinruan/NAD+ glycohydrolase/Bibliography

You will be compiling your bibliography and creating an outline of the changes you will make in this sandbox.


Bibliography

edit
  • Lee HC, Deng QW, Zhao YJ. The calcium signaling enzyme CD38 - a paradigm for membrane topology defining distinct protein functions. Cell Calcium. 2022 Jan;101:102514. doi: 10.1016/j.ceca.2021.102514. Epub 2021 Dec 1. PMID: 34896700.
    • This is an article published within the last five years and published by a peer reviewed cell biology journal (Cell Calcium), which indicates that the article is a reliable and relevant source.
    • Article provides literature review of the extracellular NADase activity of typeII CD38 (enzyme found on T cells), and how the NADase breaks down NAD+ from apoptosis which is pertinent to the NAD+ synthesis pathway and immunoregulation.[1]
  • Chini EN. CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions. Curr Pharm Des. 2009;15(1):57-63. doi: 10.2174/138161209787185788. PMID: 19149603; PMCID: PMC2883294.
    • This is an article published within the last five years and published by a peer reviewed scientific journal (Current Pharmaceutical Design), which indicates the article is a reliable and relevant source.
    • Provides literature review of the importance of CD38's NADase activity as it is one of the main source of NADase activity for mammalian cells [2]
  • Fang J, Chen W, Hou P, Liu Z, Zuo M, Liu S, Feng C, Han Y, Li P, Shi Y, Shao C. NAD+ metabolism-based immunoregulation and therapeutic potential. Cell Biosci. 2023 May 10;13(1):81. doi: 10.1186/s13578-023-01031-5. PMID: 37165408; PMCID: PMC10171153.
    • This is an article published by a peer reviewed scientific article (Cell Bioscience), which indicates that the article is a reliable source.
    • Provides literature review and background of SARM1 (enzyme found on T cells), and how this enzyme functions as an intracellular NADase and the mechanism of NADase activation and inhibition in SARM1.[3]

References

edit
  1. ^ Lee, Hon Cheung; Deng, Qi Wen; Zhao, Yong Juan (2022-01). "The calcium signaling enzyme CD38 - a paradigm for membrane topology defining distinct protein functions". Cell Calcium. 101: 102514. doi:10.1016/j.ceca.2021.102514. ISSN 1532-1991. PMID 34896700. {{cite journal}}: Check date values in: |date= (help)
  2. ^ Chini, Eduardo Nunes (2009). "CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions". Current Pharmaceutical Design. 15 (1): 57–63. doi:10.2174/138161209787185788. ISSN 1873-4286. PMC 2883294. PMID 19149603.
  3. ^ Fang, Jiankai; Chen, Wangwang; Hou, Pengbo; Liu, Zhanhong; Zuo, Muqiu; Liu, Shisong; Feng, Chao; Han, Yuyi; Li, Peishan; Shi, Yufang; Shao, Changshun (2023-05-10). "NAD+ metabolism-based immunoregulation and therapeutic potential". Cell & Bioscience. 13 (1): 81. doi:10.1186/s13578-023-01031-5. ISSN 2045-3701. PMC 10171153. PMID 37165408.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)

Outline of proposed changes

edit

Click on the edit button to draft your outline.